Last updated: August 17, 2026
Mesenchymal Stem Cells may be a viable treatment option for Post Treatment Lyme Disease Syndrome (PTLDS). Stem cells have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful stem cells have a regulatory nature on the body
Scientific Case Review
Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?
Send your question to our scientific team. The NBScience head office in the United Kingdom coordinates inquiries across international network of medical centres, scientists, and specialised consultants.
- Review of the information you provide
- Relevant research and clinical program information
- A clear response focused on your situation
No obligation. Your question will be reviewed confidentially.
Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.
